Dr. Marina Stavrou is a Post-Doctoral fellow at the Neuroscience department of The Cyprus Institute of Neurology and Genetics (CING) under the supervisor of Prof. Kleopas A. Kleopa. Her main research focuses on the development of novel and translatable gene therapy approaches to treat CMT1A neuropathy. She received a BSc in Biology, an MSc in Cancer Research and Molecular Medicine and a PhD in Molecular Medicine. Marina co-invented a patent describing a CMT1A gene therapy product (WO2022119826A1). This product is currently licensed by Armatus Bio (Ohio, US). Marina has been recognized with the PK Thomas prize from the international Peripheral Nerve Society, the Panos Ioannou Junior Scientist award from CING, the best PhD thesis award from the Cyprus Biological Society and a travel grant from the International Brain Research Organization. She has also been ranked by the international CMT Association as being among the 40 scientists under 40 y.o. who impacted CMT Research. Marina works on CMT1A gene therapy for almost 10 years during which she participated in international conferences as an invited speaker and she has contributed as a reviewer for manuscripts and grant applications.